About
Minimally-invasive device for heart failure treatment
Areas of Focus
Categories
Surgical DeviceSouthwestern U.S.
Team (21)
Av Edidin, Ph.D.
Senior Vice President, Development and Manufacturing
Procyrion
executive
Carter Meyer
Procyrion
team_member
Chris Durst, PhD
Vice President, Product Development
Procyrion
executive
Elisabeth (Beth) Neely
Senior Vice President, Clinical And Regulatory Affairs
Procyrion
executive
Eric S. Fain, M.D.
Procyrion
team_member
Gerhard âGaryâ F. Burbach
Procyrion
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
336
By Phase
NA: 3
By Status
RECRUITING: 1TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05677100Lead Sponsor
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
NARecruiting
295 participants
Started: Aug 23, 2023 · Completed: Jul 31, 2026
NCT04999163Lead Sponsor
Aortix Therapy for Perioperative Reduction of Kidney Injury
NATerminated
20 participants
Started: Jul 17, 2022 · Completed: Aug 22, 2023
NCT04145635Lead Sponsor
The Aortix CRS Pilot Study
NACompleted
21 participants
Started: Feb 5, 2021 · Completed: Mar 9, 2023
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...